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Abstract 
 Crossbred bull calves at high risk for morbidity (n = 190; BW = 159 ± 68 kg) were 
received at a commercial stocker operation to evaluate the effects of meloxicam administered at 
the time of castration on performance and health through d 30 post-arrival. Calves were assigned 
randomly to receive either a whey-powder placebo (CON), 0.5 mg/kg BW meloxicam (LOW), or 
1.0 mg/kg BW meloxicam (HIGH) administered orally. Calves were vaccinated, knife-castrated, 
and received experimental treatments on d 0. Meloxicam had no effect on ADG (P ≥ 0.63), 
morbidity (P = 0.66), or mortality (P = 0.62). A second study was conducted using crossbred 
calves from the southeastern US and Mexico (n = 472; BW = 227 ± 45 kg) to evaluate effects of 
an injectable trace-mineral solution administered at time of arrival at a commercial stocker 
operation on animal performance, health, and serum concentrations of Cu, Mn, Se, and Zn on d 0 
and d 45. Calves were assigned randomly to receive saline (CON; 1.0 mL/45 kg BW) or 
injectable trace mineral (ITM; 1.0 mL/45 kg BW) on d 0. Average daily gain from d 0 to d 42, 
overall ADG from d 0 to d 139, mortality, and morbidity were not different (P ≥ 0.31) between 
treatments. Calves originating from the Southeastern US had greater (P < 0.01) overall ADG 
from d 0 to 139. There were no source effects (P ≥ 0.21) on initial serum mineral concentrations 
for Mn or Zn; however, cattle originating in Mexico had lesser serum Cu (P < 0.01) and cattle 
originating in the Southeastern US tended to have lesser serum Se (P = 0.06).  On d 45, there 
were no treatment differences (P ≥ 0.20) in serum concentrations of Cu, Mn, or Zn but cattle that 
received ITM tended (P = 0.09) to have elevated serum Se concentrations compared to those that 
received CON.
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Chapter 1  
Literature Review 
Beef production in the United States is comprised of three phases: cow-calf, growing, and 
finishing. Stocker calves in the growing phase of production play an important role in beef 
production and marketing (Johnson et al., 2010). Stocker calves represent a segment of the 
industry in which weight gain has the potential to be inexpensive relative to the cow-calf and 
finishing phases of production (Peel, 2003). As in any business, the primary goal of a stocker 
cattle producer is to increase production outputs while minimizing input costs. Maintaining 
animal health and well-being is imperative to the success of a stocker operation. Stocker calves 
typically are purchased and received weighing 136 to 363 kg (Johnson et al., 2010). Components 
of a successful stocker production system include animal nutrition, pasture management, animal 
health, marketing, risk management, and business management (Johnson et al., 2010). In 
previous studies, stocker calves grazed on spring-burned native Flint Hills pastures exhibited an 
ADG of 0.68 to 0.82 kg (Barnhardt et al., 2006). Minimizing morbidity and mortality and 
maintaining maximum animal production can be accomplished with proper management of the 
aforementioned components.  
Management Practices in Receiving Cattle 
Common management practices upon receiving of high-risk stocker calves include 
dehorning, castration, vaccination, treatment for parasites, and metaphylactic antibiotic treatment 
(Coetzee et al., 2010; USDA-APHIS, 2010; USDA-APHIS, 2012). Stressed animals are likely to 
have depressed immune function (Richeson et al., 2009). Bovine respiratory disease (BRD) is the 
leading cause of morbidity and mortality and results in significant economic losses for the beef 
industry (Woolums et al., 2005). Calves from the southeastern United States arriving on ranches 
and feedlots in the Midwest are typically assembled from various small-scale cow-calf producers 
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who are unlikely to castrate or vaccinate (NAHMS, 1998). Richeson et al. (2009) found that 
high-risk cattle originating from auction markets gained less BW and exhibited increased 
morbidity and mortality when co-mingled with an individual that was persistently infected with 
bovine viral diarrhea virus. Animal performance and carcass quality are also decreased by BRD 
morbidity (Gardner et al., 1999). Grazing cattle with known management history may have 
decreased incidence of BRD (Duff and Galyean, 2007), compared to cattle with no known 
history. 
Consumer interest in animal welfare and in pain associated with common beef-cattle 
management procedures is significant (Rollin, 2004). Castration and dehorning are considered 
painful procedures (Coetzee et al., 2010; Allen et al., 2013). Significant pain induces stress and 
contributes to immunosuppression (Anderson and Muir, 2005), morbidity, and mortality. The use 
of nonsteroidal anti-inflammatory drugs (NSAIDs) has been approved in the European Union. 
Flunixin meglumine is the only NSAID currently approved by the US Food and Drug 
Administration (FDA) for pain management in food animals; however, extra-label use is allowed 
under the Animal Medicinal Drug Use Clarification Act of 1994 (USDA-NASS, 1994). Non-
steroidal anti-inflammatory drugs can be administered preemptively or post-surgically to 
mitigate painful procedures (Coetzee, 2013; Smith, 2013). Multimodal analgesics increase 
effectiveness of NSAID treatment (Repenning, et al., 2013). 
Use of Non-Steroidal Anti-Inflammatory Drugs for Pain Mitigation 
As consumer concern for animal welfare grows, it is imperative that the beef industry 
seeks methods to ensure proper animal handling and pain mitigation during normal operational 
practices.  In a recent survey of bovine veterinarians in the US, 21% of respondents indicated 
that they administer analgesics at the time of castration (Coetzee et al., 2010). Currently, 
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NSAIDs are regularly used in beef cattle in the European Union both metaphylactically and post-
operatively. Required withdrawals for meat and milk of cattle treated with meloxicam in the 
European Union are 15 days and 5 days, respectively (EMA, 2006).  In the US, NSAIDs are 
allowed under the Animal Medicinal Drug Use Clarification Act of 1994, which permits extra-
label use of NSAIDs in beef cattle when administered by a veterinarian (USDA-NASS, 1994). 
Oral meloxicam tablets are readily available and inexpensive (Smith, 2013), which makes 
meloxicam an appealing option for pain management. 
Physiological Biomarkers and Behavioral Responses Indicative of Pain 
Elevated levels of physiological biomarkers such as plasma concentrations of substance P 
and cortisol are indicative of pain response in mammals (Coetzee et al., 2013). Substance P is 
secreted by nerves, macrophages, and lymphocytes; it has inflammatory effects in immune and 
epithelial cells during viral infections of beef cattle (O’Connor et al., 2004). Cortisol is a 
glucocorticoid that has anti-inflammatory and immunosuppressive properties; cortisol 
concentrations in the blood are elevated in response to physical or psychological stress (Willet 
and Erb, 1972). Cortisol concentrations in serum are elevated during painful procedures such as 
castration (Thüer et al., 2007).  Knife and band castration were shown to elevate both substance 
P and cortisol (Fisher et al., 1996; Earley and Crowe, 2002).  Dehorning has also been associated 
with increased cortisol (Stafford and Mellor, 2005; Heinrich et al., 2009).  
Non-steroidal anti-inflammatory drugs decrease inflammation by reducing prostaglandin 
synthesis through inhibition of cyclooxygenase (COX) and by stimulating release of 
prostaglandins that mediate inflammation (Anderson and Muir, 2005). Cyclooxygenase exists in 
two isoforms: COX-1, which is expressed in the central system, the peripheral nervous system, 
and the gastrointestinal tract, and COX-2, which becomes active only after cell damage and cell 
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death (Smith and Langenbach, 2001). Meloxicam (Metacam®, Boehringer Ingelheim LTD, 
Burlington, ON) is an NSAID from the oxicam class that exhibits preferential binding to COX-2 
receptors (Coetzee, 2013); NSAIDs that are selective for COX-2 tend to create fewer negative 
gastrointestinal side effects than non-specific COX inhibitors (Radi and Khan, 2006). Other 
commonly used NSAIDs include flunixin meglumine, ketoprofen, and phenylbutazone, which 
are non-specific COX inhibitors (Anderson and Muir, 2005).  
Pain response in animals can be quantified through behavioral indices, including chute 
exit velocity, subjective chute score, feed intake, time spent at the feed bunk, and time spent 
lying down. Such behavioral changes can be monitored with motion-recording devices (Theurer 
et al. 2012). The aforementioned behavioral changes have the potential to affect animal 
production. Repenning et al. (2013) treated weanling bulls with oral meloxicam before and after 
band castration and reported no treatment effects on subjective chute scores or chute exit 
velocities. Theurer et al. (2012) observed that Holstein calves administered oral meloxicam at the 
time of dehorning spent more time standing up and walking from d 1 through 5 following 
dehorning than calves that did not receive analgesic treatment.  
The Approval and Use of NSAIDs in the United States 
Flunixin meglumine, at a dosage of 2.2 mg/kg BW via i.v., is the only NSAID currently 
approved by the FDA to treat cattle within the United States for BRD, inflammation associated 
with endotoxemia, and mastitis. Flunixin meglumine has a plasma half-life of 3 to 8 h, a meat 
withdrawal time of 4 d, and a milk withdrawal time of 36 h (Coetzee, 2013).  
Ketoprofen can be used extra-label at a dosage of 3 mg/kg BW i.v. or i.m.; it has a plasma 
half-life of 0.42 hours (Coetzee, 2013). Ketoprofen is more effective in reducing serum cortisol 
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after castration than local anesthesia (Earley and Crowe, 2002). Ting et al. (2003), reported that a 
single i.v. dose of ketoprofen reduced cortisol levels in response to castration. 
Phenylbutazone can be used extra-label at a dosage of 10 mg/kg BW with a follow-up 
dose of 5 mg/kg BW every 48 h, and has a plasma half-life of 40 to 55 h (Coetzee, 2013). 
Meloxicam can be used extra-label in the United States at a dosage of 0.5 mg/kg BW i.v.  or 0.5-
1.0 mg/kg BW orally; it has a plasma half-life of 27 h (Coetzee, 2013).  
Use of Meloxicam to Mitigate Pain from Castration and Increase Animal Performance 
The ease of oral NSAID administration and its relatively long half-life make meloxicam a 
promising candidate for analgesic use in the beef industry. The mean bioavailability of 
meloxicam after oral administration of 1 mg/kg BW is 100 % with a plasma elimination half-life 
of 27 h (Coetzee, 2013). The long half-life suggests that effects of meloxicam may last several 
days after a single treatment. Meloxicam is currently approved for use in beef cattle in the 
European Union and Canada for adjunctive therapy of acute respiratory disease, diarrhea, and 
acute mastitis when administered i.v. or s.c. at 0.5 mg/kg, or orally at 0.5 to 1.0 mg/kg (EMA, 
2006). Van Engen et al. (2014) found that administering oral meloxicam to beef steers following 
transportation tended to reduce serum cortisol concentrations. Coetzee et al. (2012) reported that 
ADG was unaffected by oral meloxicam treatment upon receiving; however, subjective diagnosis 
of BRD was decreased in animals that received meloxicam. Conversely, oral meloxicam 
administered before and after band castration had no effect on animal performance or 
physiological responses (Repenning et al., 2013). In addition, Allen et al. (2012) found that 
administering oral meloxicam to Holstein calves in conjunction with a local anesthetic after 
dehorning decreased serum substance P, prostaglandin E2, and cortisol. Meloxicam administered 
intravenously after dehorning resulted in decreased heart and respiratory rates (Heinrich et al., 
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2009). No effect of timing of meloxicam administration was apparent in Holsteins when the drug 
was administered either prior to or at dehorning (Allen et al., 2013).  
The castration procedure has a negative short-term effect on calf performance. Coetzee et 
al. (2012) reported that castration decreased ADG and DMI from d 1 to 14 following the 
procedure. In another study, castration tended to decrease ADG from d 0 to 14 but not from d 0 
to 84 (Warnock et al., 2012). Massey et al. (2011) reported that cattle received as bulls with an 
average BW of 209 kg at the time of castration exhibited decreased ADG and increased 
morbidity relative to cattle that had been castrated during preconditioning; moreover, HCW was 
decreased and d-to-market was increased in animals that were castrated upon receiving compared 
to animals that were received as steers. Meloxicam administered subcutaneously to high-risk 
stocker cattle decreased the number of lung lesions at harvest and increased overall BW and 
ADG from d 70 until harvest (Friton et al., 2005). While meloxicam has been shown to decrease 
physiological biomarkers indicative of pain response, animal performance, morbidity, and 
mortality appear to be unchanged due to NSAID use. 
Mineral Supplementation of Stocker Cattle 
There are 17 minerals required by beef cattle including the microminerals Cu, Mn, Se, 
and Zn. The minimum requirements of growing and finishing beef cattle for Cu, Mn, Se and Zn 
are 10, 20, 0.1, and 30 ppm dietary DM, respectively (NRC, 2000). Stocker cattle are generally 
offered forage-based diets (Johnson et al., 2010); however, they may be fed up to 15% of diet 
DM in the form of concentrates (Greene, 2000). Mineral requirements of stocker cattle are 
generally met in large part by their diets; any deficiencies must be corrected by providing 
adequate supplementation (Greene, 2000).  
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Kansas native grasses vary in trace mineral content by stage of growth and season; that 
variability in addition to animal selectivity is important to recognize when identifying 
deficiencies (Arthington et al., 1994). Forage nutrient availability is dependent on plant species, 
maturity, season, and soil quality (Anderson and Fly, 1955; Kamstra et al., 1958; Smith and 
Owensby, 1978). Because of this variability, calves assembled from auction markets can 
potentially exhibit a range of mineral deficiencies. The most common way to meet minimum 
nutrient requirements and prevent mineral deficiencies in a stocker operation is to provide 
mineral supplementation (Greene, 2000). Mineral supplementation can be offered in a variety of 
forms, including oral drench, oral bolus, self-fed mineral supplements, and injectable 
supplements. The use of an injectable trace-mineral supplement (ITM) potentially bypasses gut-
level antagonisms during the absorption process and can be used to elevate mineral status in 
preparation for periods of stress (Pogge et al., 2012). 
Trace Minerals: Copper, Manganese, Selenium and Zinc 
The trace minerals Cu, Se, Mn and Zn are commonly provided in mineral supplements. 
Trace mineral nutrition supports growth and immune function (Galyean et al., 1999; Underwood 
and Suttle, 1999; Suttle, 2010). Zinc in particular has been shown to improve animal health when 
provided in supra-nutritional concentrations during times of disease challenge (Chirase et al., 
1991).  
Copper functions as a component of enzymes (McDowell, 1992) associated with Fe 
metabolism, elastin and collagen formation, and melanin production (Pond et al., 2005). The 
presence of absorptive antagonists of Cu, such Mo and S, must be considered when adjusting 
dietary Cu concentration for dietary Cu availability. Dietary Cu requirements are increased by 
the presence of dietary Mo and S. The 10 mg/kg BW requirement provides adequate dietary Cu 
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as long as the diet does not exceed 0.25% S or 2 mg/kg BW Mo (NRC, 2000). Molybdenum 
metabolism forces Cu to bind with plasma albumin, hindering absorption (Thornton et al., 1972). 
Elevated dietary S may cause formation of Cu-sulfides, which also reduce Cu absorption (Suttle, 
1974). Signs of Cu deficiency include anemia, ataxia, bone abnormalities, hair loss, 
cardiovascular lesions, hemorrhages, and reproductive failure (Pond et al., 2005). 
Manganese plays an important role in bone formation, as it contributes to the formation 
of the organic bone matrix (Pond et al., 2005). Manganese also activates enzymes including 
hydrolases, kinases, transferases, and decarboxylases. Manganese requirements for reproduction 
are greater than those for growth and performance. Reproductive failure, poor skeletal 
development, and skeletal abnormalities are symptoms of Mn deficiency (NRC, 2000). 
Selenium metalloenzymes prevent oxidative damage to body tissues (Hoekstra et al., 
1974) and deiodinates thyroxine to make it metabolizable (Arthur et al., 1990). The functions of 
Se and Vitamin E are related; when a diet is deficient in Vitamin E, additional Se is required to 
prevent muscle abnormalities (Miller et al., 1988). White muscle disease, or nutritional muscular 
dystrophy, is common in Se-deficient calves. If the heart muscle is affected, Se deficiency can 
result in mortality. Because there is a narrow margin between Se deficiency and Se toxicity, it is 
also important to consider availability of the Se source (Pond et al., 2005). 
Zinc activates various metalloenzymes and is also an essential component of important 
enzymes responsible for nucleic acid, protein, and carbohydrate metabolism (Hambidge et al., 
1986). The absorption of Zn is negatively affected by increased dietary calcium concentrations 
(Pond et al., 2005). Signs of Zn deficiency include reduced growth, reduced feed intake, reduced 
feed efficiency, listlessness, skin lesions, and alopecia (NRC, 2000). 
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Avoiding Trace Mineral Deficiency through Supplementation 
There are two types of mineral deficiencies. Type 1 deficiencies are caused by inadequate 
nutrient availability, while Type 2 mineral deficiencies are caused by antagonistic relationships 
between minerals which prevent normal absorption. Both of these types of deficiencies need to 
be considered when selecting a mineral supplementation program. Bioavailability of mineral 
supplements can vary. For example, inorganic selenite is less metabolizable than natural Se-
containing sources such as yeasts (Pehrson et al., 1989). Mineral chelates may be absorbed from 
the gut at greater rates than inorganic mineral sources (McDowell, 1996). 
 Supplementing minerals through the diet has variable effectiveness, depending on intake 
by each individual animal (Arthington and Swenson, 2004). Injectable trace mineral (ITM) 
supplements are another option available to producers that allows for targeted dosage and known 
delivery. Injectable sources of Cu, Mn, Se and Zn that are provided during initial processing of 
high-risk calves allow for rapid absorption and the possibility of improved health and animal 
performance. Arthington and Havenga (2012) found that administration of ITM to beef calves 
increased serum Cu, Se and Zn and increased bovine herpes virus-neutralizing antibody titers 
post-vaccination, compared to the control group. Improvements in reproduction and performance 
of cow-calf pairs have been observed following the administration of ITM. In cows and calves 
grazing native range, the use of an ITM improved AI pregnancy rates and subsequent calving 
distribution (Mundell et al., 2012). 
Effects of Trace Mineral Supplementation on Morbidity and Animal Performance 
Richeson and Kegley (2011) reported that administering ITM at initial processing of 
high-risk heifers improved ADG, improved feed efficiency, and decreased incidence of BRD. 
Genther and Hansen (2014b) reported that mild mineral deficiencies were induced in some cattle 
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by shipping stress and ITM was administered to evaluate effects on animal performance and 
carcass characteristics. Average daily gain was improved in ITM-treated steers compared to 
untreated steers when both groups had documented trace-mineral deficiencies; however, there 
was no difference in ADG between treatment groups when no deficiency was detected. In 
another study conducted by Genther and Hansen (2014a), liver Cu and Se concentrations 
decreased over time in steers with documented dietary deficiencies in those minerals following 
ITM administration; this was interpreted to indicate that supplemental, injectable Cu and Se were 
metabolized directly rather than stored. These researchers also reported that superoxide 
dismutase activity was increased with administration of ITM.  
Arthington et al. (2014) administered ITM to heifer calves following weaning and 
transport and found that ADG decreased in calves that received the ITM treatment versus the 
control; however, liver concentrations of Cu, Se, Mn and Zn, and humoral immune responses 
were greater in calves that received ITM treatment. Risk of BRD incidence has a greater effect 
than mineral supplementation on morbidity and treatment costs during receiving and on ADG 
and DMI during the finishing phase (Clark et al., 2006). Ward and Spears (1999) fed steers a 
low-Cu diet and concluded that stress had a greater effect on immunity than Cu status. Before 
weaning, ITM had no effect on calf BW gain; however, treated calves had increased 
concentrations of liver Cu and Se and lesser liver Fe compared to untreated calves. After 
weaning, ITM-treated calves had increased liver concentrations of Cu, Se, and Zn and decreased 
ADG compared to untreated calves. Stocker heifers treated with ITM had greater antibody titers 
and ADG than untreated heifers 177 d after treatment (Arthington and Havenga, 2012). This 
indicates that while BRD has a greater effect on morbidity and ADG than mineral 
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supplementation, treatment with ITM may reduce the effect of BRD on animal health and 
performance. 
Other studies have observed potential breed effects on mineral utilization. Pogge et al. 
(2012) found that after administering ITM, Simmental steers had lesser plasma Mn than Angus 
steers; liver concentrations of Se and Cu in both breeds increased after receiving ITM. Littledike 
et al. (1995) found that Limouisin cattle exhibited greater liver Cu and Zn levels than Braunvieh, 
Charolais, Gelbvieh, Hereford, Red Poll, Pinzgauer and Simmental cattle; moreover, they found 
no difference in serum Cu or Zn concentrations between breeds. 
The trace mineral status of incoming cattle plays a role in the magnitude of response to 
trace mineral supplementation. Deficient animals have had greater response to ITM than animals 
with adequate trace mineral statuses (Genther and Hansen, 2014a). This indicates that 
geographical source of incoming cattle may also affect the magnitude of response to trace 
mineral supplementation, as species of forages and soil-mineral availability vary by region 
(Anderson and Fly, 1955; Dargatz and Ross, 1996). Trace mineral supplementation in the form 
of ITM allows for targeted delivery at known dosages and is not dependent on animal intake 
(Arthington and Swenson, 2004). While ITM supplementation has been shown to increase trace 
mineral status and decrease morbidity in beef cattle, its effects on animal performance have been 
equivocal.  
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Chapter 2  
Effects of meloxicam administered orally at time of castration on 
weight gain, morbidity and mortality in newly-received, high-risk 
feedlot calves 
 
Abstract 
A 30-d trial was conducted using crossbred bull calves (n = 190; initial BW = 350 ± 150 
lbs) received at a commercial stocker operation to evaluate effects of meloxicam administered at 
the time of castration on performance and health. Bull calves at high risk for bovine respiratory 
disease (BRD) were sorted into 3 groups based upon individual purchase BW and assigned 
randomly to treatments within weight blocks: pasteurized sweet-whey placebo (CON), 0.5 
mg/2.2 lb (0.5 mg/kg) BW meloxicam (LOW), or 1.0 mg/2.2 lb (1.0 mg/kg) BW meloxicam 
(HIGH). Calves received experimental treatments, were vaccinated, surgically castrated, and 
dehorned (if warranted) on d 0. Individual BW was recorded on d 7 and d 30. Morbidity and 
mortality were documented throughout the 30-d trial. Individuals identified as having BRD by 
feedlot personnel were treated according to site protocol. Average daily gain across all treatment 
groups was -0.15 lbs (0.07 kg) from d 0 to 7 and was 2.01 lbs (0.91 kg) from d 8 to 30. There 
were no treatment differences (P ≥ 0.63) in ADG. There were no effects (P ≥ 0.62) of treatment 
on mortality or morbidity. Treatment of bull calves with meloxicam immediately prior to 
castration did not affect calf performance or health.  
Key Words: calves, castration, morbidity, oral meloxicam, performance 
Introduction 
Castration is used commonly in the beef industry to reduce animal aggression and to 
improve carcass quality; however, it is associated with short-term reduction in ADG and an 
increase in morbidity3. These problems are more prominent in heavier, mature animals than in 
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young animals5, 13, 19. The additional stress that an animal experiences due to castration can, in 
some instances, compromise immune responses against bovine respiratory disease (BRD). Steers 
not having to withstand the additional stress of castration tend to exhibit lower incidence of BRD 
and better ADG than bulls castrated upon arrival11.  
Growing awareness of issues regarding animal welfare and pain management in livestock 
animals prompts the consideration of safe, economical, and effective compounds for pain 
mitigation.  The use of non-steroidal anti-inflammatory drugs (NSAIDs), alone or in conjunction 
with local anesthetics, reduces the pain response caused by castration7. Meloxicam, a member of 
the oxicam class of NSAIDs, is used commonly in small-animal medicine for its analgesic 
properties15. Currently, flunixin meglumine is the only NSAID approved by the United States 
Food and Drug Administration (FDA) for pain management in food animals; however, extra-
label use is allowed under the Animal Medicinal Drug Use Clarification Act 18. Orally-
administered meloxicam given 24 h prior to castration moderated physiological stress indicators 
during the first 14 d post-castration and decreased incidence of morbidity4. Meloxicam is 
currently used in the European Union and can be used extra-label in the US for adjunctive 
therapy of acute respiratory disease, diarrhea, and acute mastitis8. 
The objective of this trial was to determine the post-castration effects on BW gain, 
morbidity, and mortality in high-risk, crossbred, auction-sourced stocker calves when meloxicam 
was administered orally at the time of castration. 
Materials & Methods 
This trial was conducted according to Kansas State University Institutional Animal Care 
and Use Committee Protocol # 2939 and took place in a commercial feedlot in southeast Kansas 
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between April 2012 and June 2012. Intact bull calves (n = 190; initial BW = 350 ± 150 lbs) were 
purchased from various auction markets in the southeastern United States.  
Prior to shipment, calves were mass-medicated with a long-acting penicillina (2 mL/150 
lb (2 mL/68 kg) BW); given an i.m. injection of vaccine against infectious bovine rhinotracheitis, 
bovine viral diarrhea Types 1 and 2, parainfluenzavirus-3 and bovine respiratory syncytial virusb 
(2 mL/bull); and given an intranasal vaccine against infectious bovine rhinotracheitis, 
parainfluenzavirus-3 and bovine respiratory syncytial virusc (2 mL/bull). Calves arrived in 3 
truckloads at 1 wk intervals. Subject animals exhibited considerable phenotypic diversity, varied 
in health status, and covered a wide BW range within receiving dates.  
Prior to arrival at the feedlot, purchase BW of calves were obtained and used to stratify 
individual animals into three BW blocks (200 to 299, 300 to 399, and 400 to 499 lbs). Within 
each BW block, treatments were assigned randomly to individuals in groups of 3 utilizing a 
computerized random-number generator. One bull in each group was assigned randomly to 1 of 3 
treatments: non-medicated control, low-dose meloxicam, or high-dose meloxicam. The 
appropriate number of meloxicam tabletsd (NDC 29300-125-01, Lot # GMMH10091) required 
for each dosage were added to dry, pasteurized, sweet-whey powdere and inserted into gelatin 
capsulesf (Size #10 Capsules). Boluses were made to treat steers based on median target weights 
of 250 lbs, 350 lbs and 450 lbs for BW blocks 1, 2, and 3, respectively. Treatment dosage levels 
were made to be equivalent to 0 mg/lb (0 mg/kg) BW for control, approximately 0.5 mg/2.2 lb 
(0.5 mg/kg) BW for low-dose meloxicam, or approximately 1.0 mg/2.2 lb (1.0 mg/kg) BW for 
high-dose meloxicam. Non-medicated boluses for the control treatment contained only whey 
powder.  
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Following arrival of each group at the feedlot on consecutive Saturdays, calves were 
placed in pens by truckload, fed prairie hay and allowed ad libitum access to water. On the 
following Monday (d 0), all subject animals were individually weighed; given an intranasal 
modified live vaccine containing antigens for infectious bovine rhinotracheitis virus and 
parainfluenzavirus-3g (2 mL/bull); given an i.m. vaccine containing antigens for infectious 
bovine rhinotracheitis, bovine virus diarrhea Types 1 and 2, parainfluenzavirus-3, and bovine 
respiratory syncytial virus vaccineb (2 mL/bull); given a topical dewormerh (1 mL/22 lbs (1 
mL/10 kg) BW); and injected with a metaphylactic antibiotici (1.5 mL/100 lb (1.5 mL/45 kg) 
BW).  
All bulls were castrated on d 0 and test treatments were administered at the time of 
castration. On d 0, calves were placed into pastures at a stocking rate of 3 animals per acre and 
were supplemented with dried distillers’ grains. Animals were observed daily by full-time feedlot 
employees who were blinded to treatments. Animals were considered morbid if they appeared 
lethargic or unthrifty; they were treated for BRD according to standard feedlot protocol.  
On d 7, all subject animals were brought in from their pastures and reweighed; given a 
second dose of the intranasal modified live vaccine containing antigens for infectious bovine 
rhinotracheitis virus and parainfluenzavirus-3g (2 mL/bull); a second dose of the i.m. vaccine 
containing antigens for infectious bovine rhinotracheitis, bovine virus diarrhea Types 1 and 2, 
parainfluenzavirus-3b (2 mL/bull); a Clostridium chauvoei-septicum-novyi-sordellii-perfringens 
types C & D bacterin-toxoidj (5 mL/calf); and were metaphylactically treated with tilmicosink 
(1.5 mL/100 lbs (1.5 mL/45 kg) BW). After revaccinating on d 7 calves were placed back out 
into their respective pastures; final BW were collected and recorded on d 30. 
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Statistical Analysis: 
All processing and treatment data were recorded into a computer databasel immediately 
upon administration and transferred to a computer spreadsheetm to await export for statistical 
analysis. Performance and health data were analyzed with the MIXED and GLIMMIX 
procedures of SASn, respectively. Tests for equal variance were analyzed with the GLM 
procedure of SASn using Levene’s Test. Initial BW was utilized as a covariate for all analyses of 
equal variance. During the GLIMMIX procedure, the logit function was used to analyze binary 
observations (morbidity and mortality). Linear and quadratic contrasts were used to evaluate 
incidence of morbidity and mortality. The relationships between ADG, treatment, and time were 
analyzed using pairwise comparisons. Probability values were determined using the type III tests 
of fixed effects; P-values ≤ 0.05 were considered significant whereas P-values ranging from 0.05 
to 0.10 were considered indicative of trends. 
Results and Discussion 
Calf BW on d 0 tended (P = 0.07) to be different between treatments (Table 2.1); 
however, there were no treatment differences (P = 0.42) in final BW. All treatment groups lost 
BW between d 0 and d 7. Though ADG improved across all treatments from d 8 to 30, there was 
no effect (P ≥ 0.63) of meloxicam on ADG from d 0 to 7, d 8 to 30, or from d 0 to 30 (Figure 
2.1). Neither rates of morbidity nor mortality were affected (P ≥ 0.62) by treatment (Table 2.2) 
throughout this trial.  
In previous research, NSAIDs reduced morbidity and pain response in calves exposed to 
dehorning17 and castration7. Repenning et al.14 administered oral meloxicam to weanling 
Holstein bull calves before and after band castration and reported no effect on ADG. Meloxicam 
had no effect on quiescence (measured via movement-monitoring devices) in Holstein calves 
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following dehorning 17. Administration of ketoprofen before castration of bull calves reduced 
blood cortisol levels 7.Conversely, the timing of oral meloxicam administration relative to 
cautery dehorning in Holstein calves had no effect on blood cortisol levels 1. Sodium salicylate 
therapy following induced episodes of bovine synovitis had no effect on performance10. Coetzee 
et al. found that orally-administered meloxicam given 24 h in advance of castration had no effect 
on ADG or DMI in castrated calves at high risk for BRD6.  
Genetic and phenotypic variance in animals can also impact feed intake and efficiency. 
Genetic selection has been shown to result in increased feed intake and feed efficiency in Angus 
cattle2. Furthermore, age and maturity have been shown to affect the rate of absorption of 
meloxicam in ruminants and pre-ruminants with more mature animals exhibiting longer drug 
absorption periods12.  
Calves originating from the southeastern United States are typically assembled from 
several different small-scale cow-calf producers and are less likely to be vaccinated or castrated 
than calves which originate from large-scale cow-calf producers13. Conditions under which 
calves are commingled from multiple sources places them at greater risk for poor growth 
performance, BRD morbidity, and BRD mortality16. Morbidity caused by BRD also decreases 
carcass quality9. The calves involved in this study represented a wide range of phenotypic 
diversity and maturity as is common in stocker calf production. The diversity in maturity and 
BW exhibited by these animals, in combination with the high-risk for BRD, most likely affected 
animal health and performance to a greater extent than the experimental treatment.  
Conclusion: 
Meloxicam did not have an effect on animal performance or animal health in high-risk 
feedlot calves. In a production setting, the use of oral meloxicam administered at the time of 
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castration did not offer benefits to outweigh the cost of treatment and additional stress placed on 
the animal. 
Endnotes 
aBactracillin G® Benzathine, Aspen Veterinary Resources LTD., Liberty, MO 
bBovi-Shield Gold 5®, Zoetis, Florham Park, NJ 
cEnforce 3®, Zoetis, Florham Park, NJ 
dMeloxicam tablets USP 15mg, Unichem Pharmaceuticals USA Inc., Rochelle Park, NJ 
eSweet whey powder, Kraft Foods, Deerfield, IL 
fTorpac® gelatin capsules, Torpac Inc., Fairfield, NJ 
gNasalgen®, Merck Animal Health Inc., Summitt, NJ 
hDectomax® Pour-On, Zoetis, Florham Park, NJ 
iExcede®, Zoetis, Florham Park, NJ 
jUltrabac 7®, Zoetis, Florham Park, NJ 
kMicotil 300®, Elanco, Greenfield, IN 
lCattle Data Systems® 2012, Cattle Data Systems Inc., Enid, OK 
mExcel® 2010, Microsoft, Redmond, WA 
nSAS Version 9.4, SAS Inst. Inc., Cary, NC 
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Figures and Tables 
Figure 2.1. Receiving ADG in high-risk feedlot calves after being given oral meloxicam at a 
HIGH or LOW dose, or a placebo treatment (CON)1 at time of castration on d 0 
 
Treatment1: CON = control (placebo); LOW = 0.5 mg/2.2 lbs; HIGH = 1.0 mg/2.2 lbs 
SEM = the largest SEM of all three treatments 
P-values for Treatment Effect: Day 0 to 7 = 0.90; Day 8 to 30 = 0.63; Day 0 to 30 = 0.79 
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Table 2.1. Effects of orally-administered meloxicam on initial BW and BW on d 30 after 
receiving oral meloxicam at a HIGH or LOW dose, or a placebo treatment (CON) at time of 
castration on d 0 
                                                              Treatment1 
Item CON LOW HIGH SEM2 P-value 
Day 0, lbs 355 371 360 6.8 0.07 
Day 30, lbs 399 415 408 10.4 0.42 
Treatment
1
: CON = control (placebo); LOW = 0.5 mg/2.2 lbs; HIGH = 1.0 mg/2.2 lbs 
SEM
2 
= the largest SEM of all 3 treatments 
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Table 2.2. Morbidity and mortality observed in high-risk feedlot calves during a 30-d receiving 
period after being given oral meloxicam at a HIGH or LOW dose, or a placebo treatment (CON) 
at time of castration on d 0 
                                                 Treatment1 
Item CON LOW HIGH SEM2 P-value 
Mortality, % 11.95       6.03 0.17 29.480 0.62 
Morbidity, % 12.25     19.51 17.35 7.030 0.66 
Treatment1: CON = control (placebo); LOW = 0.5 mg/2.2 lbs; HIGH = 1.0 mg/2.2 lbs 
SEM2 = the largest SEM of all 3 treatments  
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Chapter 3  
The effects of injectable trace mineral supplementation on the 
performance and health of high-risk stocker cattle grazed on native 
Flint Hills pastures 
 
 
Abstract 
Crossbred beef calves at high risk of developing bovine respiratory disease (BRD) and 
originating in the southeastern United States and Mexico (n = 472; initial BW = 227 ± 45 kg) 
were assigned randomly within geographical source to receive an s.c. injection of  trace-mineral 
solution (15 mg/mL Cu, 10 mg/mL Mn, 5 mg/mL Se, and 60 mg/mL Zn; ITM) at a dose of 1.0 
mL/45 kg BW or an equivalent control dose of 0.9% saline (CON) upon arrival at the ranch. 
Calves were then allowed to graze on native tallgrass pastures and were observed daily for 
clinical signs of disease. Trace mineral status was evaluated using serum collected on d 0 and d 
45. Final BW was recorded upon shipment at the end of the grazing season (average time on 
pasture = 139 d, range = 124 to 164 d). There were no treatment × source interactions (P ≥ 0.23) 
for ADG from d 0 to d 42, d 43 to d 139, or d 0 to d 139; therefore, main effects of treatment and 
source were reported. Average daily gain from d 0 to d 42, and overall ADG were not affected (P 
≥ 0.31) by treatment. Average daily gain from d 43 to d 139 was greater in animals that did not 
receive ITM compared to those that did (P = 0.04). Neither morbidity nor mortality was affected 
(P ≥ 0.32) by treatment. There was no effect (P ≥ 0.21) of animal origin on initial serum 
concentrations of Mn and Zn; however, calves originating from Mexico had lesser (P < 0.01) 
initial serum Cu and tended (P = 0.06) to have greater initial serum Se. Levels of serum Cu, Mn, 
and Zn on d 45 did not differ (P ≥ 0.20) between treatments; however, animals given ITM tended 
(P = 0.09) to have greater concentration of serum Se on d 45 versus calves administered CON. In 
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this study, administration of ITM upon receiving of high-risk crossbred beef calves did not affect 
overall ADG, morbidity, or mortality. Stocker calf source influenced both ADG and initial trace 
mineral status upon arrival. Treating with ITM may affect serum selenium concentrations. 
 
Key Words: calves, injectable trace mineral, morbidity, performance, supplement 
 
Introduction 
Although acute symptoms of trace mineral deficiencies are rarely observed in production 
settings, subclinical symptoms of deficiency are observed as poor animal health, performance, 
and reproductive failure (Underwood and Suttle, 1999; Suttle, 2010). Variability in initial 
mineral status, absorption efficiency, and stress among individual animals can cause a wide 
range of mineral statuses within a group of calves (Duff and Galyean, 2007). Forage nutrient 
availability also plays a role in contributing to trace mineral deficiency (Greene, 2000), as native 
forages are typically low in trace minerals (Umoh et al., 1982). 
 Adequate supplementation of trace minerals is necessary to maximize animal health and 
performance (Chirase et al., 1991; Galyean et al., 1995; Arthington et al., 2014). Mineral 
requirements for stressed and high-risk cattle are greater than that of non-stressed cattle due to 
the interactive relationship between stress and dry matter intake (NRC, 1996). Stress can 
aggravate mineral deficiencies (NRC, 1996) and contribute to immunosuppression (Galyean et 
al., 1999; Anderson and Muir, 2005; Richeson et al., 2009), morbidity (Richeson et. al., 2009), 
and can result in mortality (Edwards, 1996). Trace mineral supplementation may improve animal 
health and performance during times of stress (Pogge et al., 2012). 
 With injectable trace minerals, the amount of trace mineral administered to the animal is 
consistent and not susceptible to the variability associated with free-choice intake (Arthington 
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and Swenson, 2004; Duff and Galyean, 2007). Products of this type have improved feed 
efficiency and increased DMI (Clark et al., 2006) and ADG (Richeson and Kegley, 2011) of beef 
calves fed in confinement.  
 The objective of this study was to evaluate the effects of ITM in newly-received, high-
risk stocker calves on morbidity, mortality, ADG, and serum mineral concentrations. 
Materials and Methods 
 A 139-d trial was conducted according to Kansas State University Institutional Animal 
Care and Use Committee Protocol #3404. This study took place on a commercial ranch in the 
Flint Hills of Kansas in the late winter through early summer of 2014. Crossbred beef calves at 
high risk for developing BRD (n = 472; initial BW = 227 ± 45 kg) were purchased from auction 
markets in the southeastern United States and Mexico and were received in 6 truckloads on 
consecutive weeks between February 14 and March 23. Prior to shipment from their respective 
points of origin, calves were administered vaccinations for Haemophilus somnus, Manheimia 
haemolytica, Pasturella bacterin-toxoid (2 mL/calf; Pro-Bac 3®, Vetbio, Inc., San Angelo, TX), 
bovine respiratory syncytial virus, parainfluenza 3, and infectious bovine rhinotracheitis (2 
mL/calf; Enforce 3®, Zoetis, Florham Park, NJ). Tulathromycin (1.1 mL/45 kg BW; Draxxin®, 
Zoetis, Florham Park, NJ) was also administered to all calves prior to shipment to the ranch.  
Upon arrival at the ranch on d 0, calves were hot-iron branded and were vaccinated for 
bovine respiratory syncytial virus, parainfluenzavirus-3, infectious bovine rhinotracheitis, and 
bovine viral diarrhea types 1 and 2 (2 mL/calf; Bovishield Gold 5®, Zoetis, Florham Park, NJ), 
and were dewormed topically with doramectin (1 mL/10 kg BW; Dectomax® Pour-On, Zoetis, 
Florham Park, NJ).  
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Calves were blocked by arrival date and gonad status (i.e., bull or steer), and assigned 
randomly within geographical source to receive an s.c. injection of trace-mineral solution (ITM; 
Multimin 90®, Multimin USA, Fort Collins, CO) at a dose of 1.0 mL/45 kg BW or an equivalent 
dose of 0.9% saline (CON; Amtech, IVX Animal Health Inc., St. Joseph, MO) during post-
arrival processing; ITM contained 15 mg/mL Cu, 10 mg/mL Mn, 5 mg/mL Se, and 60 mg/mL 
Zn. Both ITM and CON treatments were administered in the left side of the neck. At that time, 
blood samples were collected from a subset of cattle originating from the southeastern US (n = 
44) and Mexico (n = 48) that equally represented both treatments. Blood samples were collected 
from the tail vein in trace mineral tubes (BD Vacutainer® Trace Element Serum Plus Blood 
Collection Tubes, Becton, Dickinson and Co., Franklin Lakes, NJ). Blood samples were kept 
refrigerated for 48 h, placed in a centrifuge (Model J-6B Centrifuge, Beckman Coulter, Inc., 
Pasadena, CA) at 1,081 × g for 8 min and serum was poured off into clean trace mineral tubes 
and frozen.  
After calves were processed and received experimental treatments on d 0, they were 
placed in winter pastures at an average stocking rate of 1 animal per 1.21 ha, and provided with 
brome hay and a loose mineral supplement containing chlortetracycline (Table 3.1; targeted 
intake = 350 mg/calf each day; Aureomycin 50®, Zoetis, Inc., Kalamazoo, MI). 
Animals were brought in from their winter pastures, revaccinated, and intact animals 
were castrated after an average of 20 d (range = 10 – 30 d) on pasture. Booster vaccinations were 
administered to all calves for bovine respiratory syncytial virus, parainfluenzavirus-3, infectious 
bovine rhinotracheitis, and bovine viral diarrhea types 1 and 2 (2 mL/calf; Bovishield Gold 5®, 
Zoetis, Florham Park, NJ) and given a Clostridium chauvoei-septicum-novyi-sordellii-
perfringens types C & D bacterin-toxoid (5 mL/calf; Ultrabac 7®, Zoetis, Florham Park, NJ). 
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Following revaccination and castration, animals were placed back in their respective winter 
pastures. 
After an average of 42 d post-arrival (range = 37 – 46 d), calves were brought in from 
winter pastures, weighed, and were given a growth-promoting implant (36 mg/calf zeranol; 
Ralgro®, Merck Animal Health Inc., Summitt, NJ). Blood samples were collected during this 
phase of processing on d 45 from 37 of the 44 animals originating from the southeastern US in 
the group that had initial blood drawn on d 0 (7 of the southeastern calves which had been bled 
on d 0 died prior to d 45). No samples were drawn from calves originating from Mexico at this 
time. Blood samples from d 45 were kept refrigerated for 48 h, placed in a centrifuge (Model J-
6B Centrifuge, Beckman Coulter, Inc., Pasadena, CA) at 1,081 × g for 8 min and serum was 
poured off into clean trace mineral tubes and frozen. Frozen serum samples from d 0 and d 45 
were then shipped to Iowa State University College of Veterinary Medicine for trace mineral 
analysis, via inductively-coupled plasma mass spectrometry. 
A majority of the calves (n = 376) were turned out onto native Flint Hills summer 
pastures following d 42 and were provided with loose mineral containing chlortetracycline 
(Table 3.1; Aureomycin 50®, Zoetis, Inc., Kalamazoo, MI). Of the 472 calves utilized in this 
study, 96 calves that equally represented both treatment groups remained in winter pastures for 7 
more d; they were subsequently turned out into summer pastures on d 49.  
Morbidity and mortality were recorded throughout the study. Animals were observed 
daily by full-time ranch employees who were blinded to treatments. Animals were considered 
morbid if they exhibited lameness or appeared to be unthrifty or depressed. Morbid animals were 
treated with either tilmicosin (1.5 mL/45 kg BW; Micotil 300®, Elanco, Greenfield, IN) or a 
broad-spectrum cephalosporin (1.5 mL/45 kg BW; Excede®, Zoetis, Florham Park, NJ). 
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On d 139, animals were brought in from their summer pastures and final BW was recorded. 
Statistical Analysis: 
Tests for homogeneity of variance between treatments were conducted using the GLM 
procedure of SAS (SAS Version 9.4 Inst. Inc., Cary, NC) via the Levene’s Test for equal 
variance; residuals from the analysis for covariance model of baseline serum mineral 
concentrations were utilized as covariates for d 0 and d 45 serum mineral analyses. Unequal 
variance between treatments was detected for d 0 BW, d 139 BW, d 0 to d 42 ADG, d 43 to d 
139 ADG, and overall ADG (P ≤ 0.09) and was accounted for in the analyses using the 
Satterthwaite Approximation to compute the denominator degrees of freedom, and the Tukey-
Kramer test to adjust for multiple comparisons in the least squared means within the MIXED 
procedure of SAS. 
Body weights and ADG were analyzed using the MIXED procedure of SAS with animal 
as the experimental unit, treatment and source as fixed effects, and arrival date and castration 
status as random effects. The incidence of morbidity and mortality were analyzed with PROC 
FREQ procedure of SAS with animal as the experimental unit, castration status and arrival date 
as random effects, and treatment and source as fixed effects. Standard error for the incidence of 
mortality was calculated from PROC FREQ values due to uneven frequency of morbidity and 
mortality across sources and treatments. Initial BW upon arrival was utilized as a covariate for 
all binary analyses. Conditional independence between treatment and source for morbidity and 
mortality data was confirmed using the Cochran-Mantel-Haenszel Chi-square test for 
independence (P ≥ 0.96). Origin effect on initial serum mineral concentrations (d 0) and the 
comparisons for d 0 to d 45 trace mineral serum concentrations were analyzed with the GLM 
procedure of SAS with treatment as the covariate for the d 45 analysis.  
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Probability values were determined using the type III tests of fixed effects; P-values ≤ 
0.05 were considered significant and P-values ranging from 0.05 to 0.10 were considered 
indicative of trends. 
Results and Discussion 
Animal Performance, Morbidity and Mortality: 
 There were no treatment or source effects (P ≥ 0.14) on d 0 BW in calves used in this 
study. There was no treatment effect (P = 0.95) for d 139 BW but a source effect (P < 0.01) was 
observed with the cattle originating from the southeastern US having greater final BW than those 
from Mexico. A treatment × source interaction was observed in d 139 BW (P = 0.03); CON-
treated cattle originating from the southeastern US were 6.95 kg heavier than those that received 
ITM, whereas ITM-treated cattle originating from Mexico were 5.53 kg heavier than those that 
received CON. 
All calves lost weight during the first 42 d following arrival at the ranch; no differences 
(P = 0.54) between treatments were observed. From d 43 to d 139, calves that did not receive 
ITM treatment gained more weight than calves that received ITM (P = 0.04). The reason for this 
decrease in performance is unclear. Overall ADG was not different between treatments (P = 
0.31; Table 3.3).  
Arthington et al. (2014) found no difference in ADG in beef calves receiving no ITM or 
an ITM containing the same mineral concentrations as the current study, administered at 1 
mL/calf at 0, 100, and 200 d of age. Calves in that study were allowed access to free-choice 
mineral supplement. Those authors then shipped the calves 1,600 km following weaning; ADG 
during the first 14 d post-shipment was decreased in calves that had received ITM versus the 
control. Mundell et al. (2012) reported that cow and calf BW were not affected by ITM treatment 
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(1.0 mL/90 kg administered to cows; 1.0 mL/45 kg administered to calves) when using the same 
product as the current study; however, pre-breeding BCS change was greater in cows receiving 
ITM than in cows that received saline. Cows and calves had access to free-choice mineral in that 
study. These results indicated that access to free-choice mineral may mask any potential 
treatment effect of ITM on animal performance. 
When no additional form of trace mineral supplementation was provided, Arthington et 
al. (2014; a separate trial from the trial previously discussed) reported that overall ADG tended 
to increase in heifers that received ITM compared to those that received the control. Richeson 
and Kegley (2011) found that when withholding all other forms of trace mineral supplementation 
and administering either a control treatment or one of two different ITM treatments (10 mg/mL 
Cu, 20 mg/mL Mn, 5 mg/mL Se, and 20 mg/mL Zn; or 16 mg/mL Cu, 10 mg/mL Mn, 5 mg/mL 
Se, and 48 mg/mL Zn) at the same dosage level as the current study to highly stressed beef 
calves, overall ADG (d 0 to d 55) was greater in animals receiving either of the two ITM 
treatments versus the control. Berry et al. (2000) found that administering ITM containing 10 
mg/mL Cu, 20 mg/mL Mn, 5 mg/mL Se, and 20 mg/mL Zn at a constant dosage level of 3 
mL/calf (mean BW = 144 kg) upon arrival and prior to castration increased overall ADG and 
feed conversions compared to the control in crossbred calves that were not allowed access to 
other forms of mineral supplementation.  
There were no differences (P ≥ 0.32) in mortality or morbidity in calves that received 
ITM treatment compared to those that received the CON treatment (Table 3.4). Clark et al. 
(2006) reported no decrease in morbidity or mortality when administering ITM containing 
approximately five times the mineral concentration administered in the current study (5 mL/266 
kg BW; 75 mg/mL of Cu, 50 mg/mL of Mn, 25 mg/mL of Se, and 200 mg/mL of Zn) versus 
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negative controls. Conversely, Berry et al. (2000) found that the administration of ITM 
containing 10 mg/mL Cu, 20 mg/mL Mn, 5 mg/mL Se, and 20 mg/mL Zn at a constant dosage 
level of 3 mL/calf (mean BW = 144 kg) administered upon arrival and prior to castration tended 
to decrease morbidity in crossbred calves. Heightened humoral immune response of cattle that 
received ITM compared to those that received control treatments has been reported when ITM 
was administered at approximately half of label dosage recommendations (0.5 mL/45 kg; 
Arthington et al., 2014), at slightly less than label dosage recommendations (1 mL/68 kg; 
Genther and Hansen, 2014), and at label dosage recommendations with a ITM containing 20 
mg/mL less of Zn (1 mL/45 kg; Arthington and Havenga, 2012). 
Morbidity due to BRD can result in up to 82% of death loss, depending on severity of the 
illness (Edwards, 1996). Treatment costs can vary depending on severity and nature of illness 
(Johnson et al., 2010); therefore, by reducing the incidence of morbidity, treatment costs can also 
be reduced (Perino, 1992). Cattle at high risk for BRD exhibit increased rates of fever and 
treatment costs (Clark et al., 2006). Calves in the current study were considered at high risk for 
BRD, which likely affected the rate of morbidity and mortality more than ITM treatment.   
Serum Trace Mineral Concentrations: 
Serum mineral concentrations on d 0 exhibited equal variance (P ≥ 0.11) across treatment 
for Cu, Se, and Zn; however, variance across treatments tended (P = 0.07) to be unequal for 
serum Mn concentration on d 0. Initial serum concentrations of Cu (P < 0.01) were related to calf 
origin; calves of Mexican origin had lesser serum Cu concentrations than calves from the 
southeastern US. Conversely, calves originating out of the southeastern US tended (P = 0.06) to 
have lesser serum Se concentration. Initial serum concentrations of Mn and Zn were not different 
(P ≥ 0.21) between sources (Table 3.5).  
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Source of incoming stocker calves is likely to impact initial trace mineral status as 
forages native to specific areas and climates have different nutrient compositions (Anderson and 
Fly, 1955; Dargatz and Ross, 1996). Individual animal selectivity can cause variation in nutrient 
intake (Arthington et al., 1994) and season can play a role in nutrient availability from forages 
(Umoh et al., 1982; Arthington et al., 1994). Soil profile and local environmental differences can 
also affect nutrient availability (Anderson and Fly, 1955). Cattle originating from the 
southeastern US were found to be more likely to be marginally or severely deficient in Se than 
cattle originating from the central and western regions of the US (Dargatz and Ross, 1996).  
There were no differences (P ≥ 0.20) between treatments for Cu, Mn, or Zn serum 
concentrations on d 0 and d 45 in cattle originating from the southeastern US. There was a trend 
(P = 0.09) indicating an increase in serum Se concentration on d 45 versus d 0 (Table 3.6). 
Serum mineral concentrations on d 45 exhibited equal (P = 0.27) variance among treatments.  
Pogge et al. (2012) reported that plasma concentrations of Cu, Mn, Se, and Zn peaked 
within the first 24 h following treatment with ITM at the same concentration and dosage as the 
current study. They further reported that plasma concentrations of Cu, Mn and Zn returned to 
baseline concentrations within the first 24 h following ITM treatment; however, Se remained 
elevated through 24 h post-injection. This may have indicated that Cu, Mn, and Zn were rapidly 
absorbed for use or stored in the liver. In the current study, animals receiving both treatments 
were allowed access to loose mineral and the same types of forage, possibly indicating that the 
increase in serum Se concentration on d 45 was attributable to ITM. 
Arthington and Havenga (2012) reported that when ITM containing 20 mg/mL less Zn 
than in the current study was administered at the same dosage level, Mn concentrations were not 
affected by ITM treatment although serum Cu, Se, and Zn levels were greater in steers that 
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received ITM versus control. Pogge et al. (2012) found that 15 d following administration of 
ITM, Se and Cu plasma concentrations increased in animals that received ITM versus animals 
that received saline. Richeson and Kegley (2011) reported that plasma Cu and Zn were not 
affected 28 d following the administration of 1 of 2 different ITM treatments. Genther and 
Hansen (2014) found that liver Cu and Se levels were increased through at least d 30 following 
ITM treatment at a dosage level of 1.0 mL/68 kg containing the same mineral concentrations as 
the current study. Similar to the current study, Arthington et al. (2014) reported an increase in Se 
concentrations only following the administration of ITM containing the same mineral 
concentrations as the current study at one-half of the label recommended dosage.   
Conclusion: 
 In this study, the administration of ITM supplement did not affect animal performance or 
health status.  By understanding the common trace mineral deficiencies at the point of origin, 
adequate mineral supplementation can be determined to normalize trace mineral status. 
Injectable trace mineral supplementation in conjunction with a loose mineral supplement had no 
effect on animal health or ADG; but elevated levels of serum Se in animals that were marginally 
deficient. 
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Figures and Tables 
Table 3.1 Composition of mineral supplement provided to high-risk stocker cattle receiving 
either injectable trace mineral (ITM) or saline (CON) on d 0 
 
Ingredient % of Supplement1 Composition 
Bulk Salt 
Dried Distillers Grains 
Limestone Fine Fre Flo 
Monocalcium Phosphate, 21% 
Microlite2 
Zinc Sulfate, 35.5% 
Copper Sulfate, 25% 
EDDI Premix1, 9.2% 
Suppli-K3 
Nutrient composition, (calculated) 
     Salt, % 
     Ca, % 
     P, % 
     K, % 
     Mg, % 
     I, % 
     Cu, ppm 
     Zn, ppm 
57.0 
10.0 
8.0 
6.5 
5.4 
1.3 
0.5 
0.5 
0.5 
 
57.00 
4.12 
2.07 
0.32 
0.46 
0.04 
1,250 
4,600 
1ADM Alliance Nutrition Inc., Quincy, IL 
2Micro-Lite LLC, Chanute, KS 
3Bill Barr & Company, Overland Park, KS 
Supplement also included: Aureomycin 50 Granular CTC50 (Zoetis Inc., Kalamazoo, MI), Dust 
Away1, Liquapro Mill Blend 7-Molasses1, and Red Iron Oxide 
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Table 3.2 Effects of treatment and source on initial (d 0) and final (d 139) BW in high-risk 
stocker cattle receiving either injectable trace mineral (ITM) or saline (CON) on d 0  
    Treatment1          Source P-value 
Day CON ITM SEM2 SE US MEX SEM2 Treatment Source 
 
Day 0, kg3 250 254 2.2 250 253 2.9 0.14        0.45 
 
Day 139, kg3 350 350 2.3 370 330 2.7 0.95     < 0.01 
 
1Treatment: CON = 0.9% saline, 1.0 mL / 45 kg; ITM = MultiMin 90, 1.0 mL / 45 kg including 
15mg/mL of Cu, 10 mg/mL of Mn, 5 mg/mL of SE, and 60 mg/mL of Zn 
2SEM: largest of the two treatments and two sources, if different 
3Treatment by Source Intractions: Day 0, P = 0.02; Day 139, P = 0.05 
SE US: n = 314; MEX: n = 158 
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Table 3.3 Effects of treatment, source, and treatment × source on ADG in high-risk stocker cattle receiving either injectable trace 
mineral (ITM) or saline (CON) on d 0 
     Treatment1          Source P-value 
Variable CON ITM SEM1 SE US MEX SEM2 Treatment Source Treatment × 
Source 
ADG 0-42, (kg)  -0.36 -0.32 0.040 0.13 -0.80 0.046 0.54 < 0.01 0.87 
ADG 43-139, (kg) 1.22 1.16 0.017 1.15 1.23 0.017 0.04 < 0.01 0.23 
ADG 0-139, (kg) 0.73 0.71 0.015 0.82 0.62 0.019 0.31 < 0.01 0.44 
1Treatment: CON = 0.9% saline, 1.0 mL / 45 kg; ITM = MultiMin 90, 1.0 mL / 45 kg including 15mg/mL of Cu, 10 mg/mL of Mn, 5 
mg/mL of SE, and 60 mg/mL of Zn 
2SEM: largest of the two treatments and two sources, if different 
SE US: n = 314; MEX: n = 158 
47 
Table 3.4 Effects of treatment and source on morbidity and mortality in high-risk stocker cattle 
receiving either injectable trace mineral (ITM) or saline (CON) on d 0  
    Treatment1          Source    P-value 
Variable CON ITM SEM1 SE US MEX SEM2 Treatment3 Source3 
 
Morbidity, % 4.66 2.54 1.372 4.14 2.53 1.249 0.32 0.44 
 
Mortality, % 1.69 1.69 0.839 2.55 0.00 0.890 1.00 0.06 
 
1Treatment: CON = 0.9% saline, 1.0 mL / 45 kg; ITM = MultiMin 90, 1.0 mL / 45 kg including 
15mg/mL of Cu, 10 mg/mL of Mn, 5 mg/mL of SE, and 60 mg/mL of Zn 
2SEM: largest of the two treatments and two sources 
SE US: n = 314; MEX: n = 158 
3Independence of source and treatment could not be rejected by a Cochran-Mantel-Haenszel test 
(P ≥ 0.96) 
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Table 3.5 Effect of geographical source on initial serum concentrations of Cu, Mn, Se and Zn on 
d 0 in high-risk stocker cattle from the Southeastern United States (SE US) and Mexico (MEX) 
 
Mineral SE US MEX SEM3 P-value 
Cu1 1.03 0.77 0.029  < 0.01 
Mn2 16.86 8.31 4.870 0.21 
Se2 62.89 79.06 6.027 0.06 
Zn1 0.87 0.87 0.046 0.92 
1Mineral concentrations measured in parts per million (ppm) 
2Mineral concentrations measured in parts per billion (ppb) 
3SEM = largest of the two treatments 
SE US: n = 44; MEX: n = 48 
Treatment: CON = 0.9% saline, 1.0 mL / 45 kg; ITM = MultiMin 90, 1.0 mL / 45 kg including 
15mg/mL of Cu, 10 mg/mL of Mn, 5 mg/mL of SE, and 60 mg/mL of Zn 
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Table 3.6 Serum concentrations of Cu, Mn, Se and Zn in high-risk stocker cattle received from 
the Southeastern United States on d 45 after receiving either injectable trace mineral (ITM)  or 
saline (CON) on d 0  
 
  Treatment1   
Mineral Day 0 
Concentration 
CON ITM SEM4 P-value 
Cu2 1.03 1.16 1.29 0.072 0.20 
Mn3 13.86 3.90 3.89 0.323 0.98 
Se3 62.89 105.61 113.47 3.247 0.09 
Zn2 0.87 0.78 0.71 0.034 0.21 
 
1Treatments: CON = 0.9% saline, 1.0 mL / 100 lbs; ITM = MultiMin 90, 1.0 mL / 100 lbs 
including 15mg/mL of Cu, 10 mg/mL of Mn, 5 mg/mL of SE, and 60 mg/mL of Zn 
2Mineral concentrations measured in parts per million (ppm) 
3Mineral concentrations measured in parts per billion (ppb) 
4SEM = largest of the two treatments 
SE US: n = 37; MEX: n = 0 
 
